PubRank

U Gatzemeier

Author PubWeight™ 35.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2000 2.73
2 Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol 2002 2.14
3 Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 1993 2.08
4 Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer. Ann Oncol 2009 1.75
5 [Recommendations on the therapy of bronchial carcinoma]. Pneumologie 2002 1.39
6 Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol 2001 1.32
7 A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Ann Oncol 2011 1.15
8 Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer 2008 1.14
9 Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 2005 1.14
10 Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors. J Clin Oncol 2000 1.12
11 Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol 2001 1.04
12 Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase II trial. Ann Oncol 2000 1.00
13 Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur Respir J 2006 0.99
14 Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J Clin Oncol 1998 0.94
15 Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study. Lung Cancer 2012 0.93
16 Pulmonary metastasizing hemangiopericytoma. Am J Clin Oncol 1988 0.90
17 Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol 1991 0.88
18 Serum and sputum levels of cefaclor. Postgrad Med J 1979 0.87
19 Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer 2005 0.86
20 Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol 1997 0.83
21 Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases. Lung 1994 0.83
22 [Recommendations on the diagnosis of bronchial carcinoma. German Pneumology Society]. Pneumologie 2000 0.81
23 GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients. Ann Oncol 2002 0.80
24 [Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study]. Pneumologie 1998 0.80
25 Recombinant granulocyte colony stimulating factor in the treatment of small cell lung cancer: a long-term follow-up. Eur J Cancer 1995 0.79
26 [A phase II multicenter study of gemcitabine in non small cell lung cancers]. Bull Cancer 1997 0.78
27 European School of Oncology. First Euro-American Forum on Lung Cancer Treatment. Eur J Cancer 1994 0.78
28 [Chemotherapy of malignant pleural mesothelioma: have we made any progress?]. Zentralbl Chir 2008 0.78
29 [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study]. Onkologie 1984 0.78
30 An update on European randomized studies in non-small cell lung cancer. Semin Oncol 1998 0.77
31 Treatment of cancer weight loss in patients with advanced lung cancer. Oncology 1992 0.77
32 [Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)]. Pneumologie 2004 0.77
33 Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society. Onkologie 1990 0.76
34 Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II study. Ann Oncol 2001 0.75
35 Difficulties in carboplatin dosage due to different methods of serum creatinine determination. Lung Cancer 2002 0.75
36 [Several years of follow-up and results of chemotherapy of small cell bronchial carcinoma]. Prax Klin Pneumol 1983 0.75
37 [Improvement of ventilation in patients with restrictive and irreversible obstructive ventilation disorders by a single dose of theophylline]. Prax Klin Pneumol 1985 0.75
38 Megestrol acetate in cachectic patients with advanced bronchogenic cancer. Onkologie 1990 0.75
39 [Analysis of treatment outcomes in two patient cohorts (2004-2005 and 2007-2008) with limited and extensive disease small-cell lung cancer]. Pneumologie 2011 0.75
40 Gemcitabine and etoposide in small cell lung cancer: phase I and II trials. Semin Oncol 1997 0.75
41 [Bronchiectasis in Kartagener's syndrome. Indication for surgical therapy?]. Monatsschr Kinderheilkd 1983 0.75
42 Airway responsiveness to methacholine does not change during chemotherapy in patients with chronic bronchitis and bronchial carcinoma. Am Rev Respir Dis 1989 0.75
43 [Cisplatin-Vepeside versus Endoxan-Vepeside in the treatment of small cell bronchial cancer. A randomized study]. Pneumologie 1990 0.75
44 [Non-small-cell carcinoma of the lung with invasive Aspergillus infection after chemotherapy]. Dtsch Med Wochenschr 2011 0.75
45 Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer. Anticancer Drugs 2000 0.75
46 [Hemodynamics in the early postoperative period after thoracotomy and lung resection]. Thorac Cardiovasc Surg 1988 0.75
47 [Carboplatin-Vepeside in the treatment of non-small cell bronchial cancers. A phase II study]. Pneumologie 1990 0.75
48 [Tracheal stenoses--observations on the functional course following surgical correction]. Prax Klin Pneumol 1984 0.75
49 Formation of benzo[a]pyrene-DNA adducts in blood monocytes from lung cancer patients with a familial history of lung cancer. J Cancer Res Clin Oncol 1992 0.75
50 Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma. Lung Cancer 2003 0.75
51 [Chemotherapy-cum-radiotherapy-cum-surgery in the treatment of small-cell bronchogenic carcinoma (author's transl)]. Prax Klin Pneumol 1980 0.75
52 [Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. Onkologie 1985 0.75
53 [Discrepancy between the cytologic and histologic classification of bronchial cancer]. Prax Klin Pneumol 1985 0.75
54 Chemotherapy (CAV) and surgical resection as combined modality in the therapy of small-cell lung cancer. Panminerva Med 1986 0.75
55 [Acute exogenous allergic alveolitis--6 cases after loading mouldy barley]. Prax Klin Pneumol 1981 0.75
56 Clinical and functional development of sarcoidosis considering the results of bronchoalveolar lavage. Panminerva Med 1987 0.75
57 [Phase III therapy study in patients with small cell bronchial cancer]. Onkologie 1988 0.75
58 Somatostatin receptor scintigraphy in the staging of small cell lung cancer. Nucl Med Commun 1996 0.75
59 [Possibilities of chemotherapy in patients with bronchial cancer]. Rontgenblatter 1988 0.75
60 [Bronchial carcinoma: demands on the clinician and radiologist]. Rontgenblatter 1988 0.75
61 [Chemotherapy of inoperable endothoracic tumours (results of the Karrer and aco polycytostatic therapy) (author's transl)]. Prax Klin Pneumol 1979 0.75
62 [Diagnosis, clinical aspects and therapy of bronchial adenoma with endoscopic examples]. Prax Klin Pneumol 1983 0.75